Elipovimab(TD-VK617026) is a research-grade recombinant antibody targetingenv/Env polyprotein. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.
Species reactivity
Human immunodeficiency virus 1 (HIV-1)
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species
Human
Isotype
IgG1, lambda
Clonality
Monoclonal
Target
env/Env polyprotein
Endotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q03805
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names
GS-HIV, 2101210-43-7
Caption
Detects HIV-1 Envpolyprotein in indirect ELISAs. ### SEC-HPLC detection for Research Grade Elipovimab. | SDS-PAGE for Research Grade Elipovimab.
Note
For research use only. Not suitable for clinical or therapeutic use.